-46.4%
GFS vs GSK
+0.3%
-46.7%
-59.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +6.2% | -0.2% | +6.4% | +6.1% |
| 7D | -7.8% | +1.7% | -9.5% | -6.7% |
| 30D | -19.7% | +7.0% | -26.7% | -16.8% |
| 3M | -23.1% | -2.7% | -20.5% | -23.4% |
| 6M | -46.4% | +1.4% | -47.8% | -45.6% |
| All | -46.4% | +0.3% | -46.7% | -45.6% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling